[1]
|
Gnanadurai, R. and Fifer, H. (2020) Mycoplasma genitalium: A Review. Microbiology (Reading, England), 166, 21-29.
https://doi.org/10.1099/mic.0.000830
|
[2]
|
Martin, D.H., Manhart, L.E. and Workowski, K.A. (2017) Mycoplasma genitalium from Basic Science to Public Health: Summary of the Results from a National Institute of Allergy and Infec-tious Diseases Technical Consultation and Consensus Recommendations for Future Research Priorities. The Journal of Infectious Diseases, 216, S427-s430.
https://doi.org/10.1093/infdis/jix147
|
[3]
|
Raj, J.S., Rawre, J., Dhawan, N., et al. (2022) Mycoplasma genitalium: A New Superbug. Indian Journal of Sexually Transmitted Diseases and Aids, 43, 1-12. https://doi.org/10.4103/ijstd.ijstd_103_20
|
[4]
|
Hosseininasab-Nodoushan, S.A., Ghazvini, K., Jamialahmadi, T., et al. (2022) Association of Chlamydia and Mycoplasma Infections with Susceptibility to Ovarian Cancer: A Systematic Review and Meta-Analysis. Seminars in Cancer Biology, 86, 923-928. https://doi.org/10.1016/j.semcancer.2021.07.016
|
[5]
|
Yu, J., Zhou, Y., Luo, H., et al. (2023) Mycoplasma genita-lium Infection in the Female Reproductive System: Diseases and Treatment. Frontiers in Microbiology, 14, Article ID: 1098276. https://doi.org/10.3389/fmicb.2023.1098276
|
[6]
|
Qing, L., Song, Q.X., Feng, J.L., et al. (2017) Preva-lence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Ureaplasma urealyticum Infec-tions Using a Novel Isothermal Simultaneous RNA Amplification Testing Method in Infertile Males. Annals of Clinical Microbiology and Antimicrobials, 16, Article No. 45.
https://doi.org/10.1186/s12941-017-0220-2
|
[7]
|
王彦彬, 诸靖宇, 李瑞鹏, 等. 实时荧光核酸恒温扩增技术在泌尿生殖道解脲脲原体感染中的应用[J]. 中华医院感染学杂志, 2016, 26(23): 5322-5324.
|
[8]
|
杜强, 洪锴, 潘伯臣. 两种检测男性生殖道沙眼衣原体和解脲支原体方法的对比[J]. 北京大学学报(医学版), 2021, 53(4): 785-788.
|
[9]
|
薛国爽. 28072例女性生殖道支原体培养及药敏结果分析[D]: [硕士学位论文]. 重庆: 重庆医科大学, 2022.
|
[10]
|
Machalek, D.A., Tao, Y., Shilling, H., et al. (2020) Prevalence of Mutations Associated with Resistance to Macrolides and Fluoroquinolones in Mycoplasma genitalium: A Systematic Review and Meta-Analysis. The Lancet Infectious Diseases, 20, 1302-1314. https://doi.org/10.1016/S1473-3099(20)30154-7
|
[11]
|
Gosse, M., Lysvand, H., Pukstad, B., et al. (2016) A Novel Simple Probe PCR Assay for Detection of Mutations in the 23S rRNA Gene Associ-ated with Macrolide Resistance in Mycoplasma genitalium in Clinical Samples. Journal of Clinical Microbiology, 54, 2563-2567. https://doi.org/10.1128/JCM.01233-16
|
[12]
|
Ke, W., Li, D., Tso, L.S., et al. (2020) Macrolide and Fluoroquinolone Associated Mutations in Mycoplasma genitalium in a Retrospective Study of Male and Female Patients Seeking Care at a STI Clinic in Guangzhou, China, 2016-2018. BMC Infectious Diseases, 20, Article No. 950. https://doi.org/10.1186/s12879-020-05659-3
|
[13]
|
Jensen, J.S., Cusini, M., Gomberg, M., et al. (2022) 2021 Euro-pean Guideline on the Management of Mycoplasma genitalium Infections. Journal of the European Academy of Derma-tology and Venereology: JEADV, 36, 641-650.
https://doi.org/10.1111/jdv.17972
|
[14]
|
Soni, S., Horner, P., Rayment, M., et al. (2019) British Association for Sexual Health and HIV National Guideline for the Management of Infection with Mycoplasma genitalium (2018). Inter-national Journal of STD & AIDS, 30, 938-950.
https://doi.org/10.1177/0956462419825948
|
[15]
|
Workowski, K.A., Bachmann, L.H., Chan, P.A., et al. (2021) Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recommendations and Reports: Morbidity and Mortality Weekly Report Recommendations and Reports, 70, 1-187. https://doi.org/10.15585/mmwr.rr7004a1
|
[16]
|
Read, T.R.H., Fairley, C.K., Murray, G.L., et al. (2019) Outcomes of Resistance-Guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation. Clinical In-fectious Diseases: An Official Publication of the Infectious Diseases Society of America, 68, 554-560. https://doi.org/10.1093/cid/ciy477
|
[17]
|
Durukan, D., Read, T.R.H., Murray, G., et al. (2020) Resistance-Guided Antimicrobial Therapy Using Doxycycline-Moxifloxacin and Doxycycline-2.5 g Azithromycin for the Treatment of My-coplasma genitalium Infection: Efficacy and Tolerability. Clinical Infectious Diseases: An Official Publication of the In-fectious Diseases Society of America, 71, 1461-1468. https://doi.org/10.1093/cid/ciz1031
|
[18]
|
Vodstrcil, L.A., Plummer, E.L., Doyle, M., et al. (2022) Combination Therapy for Mycoplasma genitalium, and New Insights into the Utility of parC Mutant Detection to Improve Cure. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 75, 813-823. https://doi.org/10.1093/cid/ciab1058
|
[19]
|
Le Roy, C., Bébéar, C. and Pereyre, S. (2020) Clinical Evaluation of Three Commercial PCR Assays for the Detection of Macrolide Resistance in Mycoplasma genitalium. Journal of Clinical Microbiology, 58, e01478-19.
https://doi.org/10.1128/JCM.01478-19
|
[20]
|
Guschin, A., Ryzhikh, P., Rumyantseva, T., et al. (2015) Treatment Efficacy, Treatment Failures and Selection of Macrolide Resistance in Patients with High Load of Mycoplasma genitali-um during Treatment of Male Urethritis with Josamycin. BMC Infectious Diseases, 15, Article No. 40. https://doi.org/10.1186/s12879-015-0781-7
|
[21]
|
刘亚丽, 张文娟, 王洁, 等. 脲原体属和人型支原体体外药物敏感性及其对喹诺酮类药物耐药机制分析: 单中心回顾性研究[J]. 协和医学杂志, 2019, 10(3): 249-256.
|
[22]
|
Couldwell, D.L., Tagg, K.A., Jeoffreys, N.J., et al. (2013) Failure of Moxifloxacin Treatment in Myco-plasma genitalium Infections Due to Macrolide and Fluoroquinolone Resistance. International Journal of STD & AIDS, 24, 822-828.
https://doi.org/10.1177/0956462413502008
|
[23]
|
Murray, G.L., Bodiyabadu, K., Vodstrcil, L.A., et al. (2022) parC Variants in Mycoplasma genitalium: Trends over Time and Association with Moxifloxacin Failure. Antimicrobial Agents and Chemotherapy, 66, e0027822.
https://doi.org/10.1128/aac.00278-22
|
[24]
|
Fernández-Huerta, M., Bodiyabadu, K., Esperalba, J., et al. (2019) Mul-ticenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Re-sistance in Mycoplasma genitalium. Journal of Clinical Microbiology, 57, e00886-19. https://doi.org/10.1128/JCM.00886-19
|
[25]
|
Conway, R.J.H., Cook, S., Malone, C., et al. (2020) Clearance of My-coplasma genitalium Infection with Moxifloxacin in the Presence of Quinolone Resistance-Associated Mutations. Sex-ually Transmitted Diseases, 47, 197-198.
https://doi.org/10.1097/OLQ.0000000000001095
|
[26]
|
Murray, G.L., Bodiyabadu, K., Danielewski, J., et al. (2020) Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations. The Journal of Infectious Diseases, 221, 1017-1024.
|
[27]
|
Ando, N., Mizushima, D., Takano, M., et al. (2023) Effectiveness of Sitafloxacin Monotherapy for Quinolone-Resistant Rectal and Urogenital Mycoplasma genitalium Infections: A Prospective Cohort Study. The Journal of Antimicrobial Chemotherapy, 78, 2070-2079. https://doi.org/10.1093/jac/dkad208
|
[28]
|
Jensen, J.S., Cusini, M., Gomberg, M., et al. (2016) 2016 European Guideline on Mycoplasma genitalium Infections. Journal of the European Academy of Dermatology and Ve-nereology: JEADV, 30, 1650-1656.
https://doi.org/10.1111/jdv.13849
|
[29]
|
Le Roy, C., Touati, A., Balcon, C., et al. (2021) Identification of 16S rRNA Mutations in Mycoplasma genitalium Potentially Associated with Tetracycline Resistance in Vivo but Not Selected in Vitro in M. genitalium and Chlamydia trachomatis. The Journal of Antimicrobial Chemotherapy, 76, 1150-1154. https://doi.org/10.1093/jac/dkab016
|
[30]
|
唐箫, 陈娇, 杨菁. 生殖支原体感染的治疗方案及耐药情况研究进展[J]. 中国计划生育和妇产科, 2023, 15(3): 39-42.
|
[31]
|
Glaser, A.M., Geisler, W.M., Ratliff, A.E., et al. (2019) Two Cases of Multidrug-Resistant Genitourinary Mycoplasma genitalium Infection Successfully Eradicated with Minocycline. International Journal of STD & AIDS, 30, 512-514.
https://doi.org/10.1177/0956462418816757
|
[32]
|
Clarke, E.J., Vodstrcil, L.A., Plummer, E.L., et al. (2023) Efficacy of Minocycline for the Treatment of Mycoplasma genitalium. Open Forum Infectious Diseases, 10, ofad427. https://doi.org/10.1093/ofid/ofad427
|
[33]
|
苏晓红. 生殖支原体感染的诊疗进展[J]. 皮肤科学通报, 2021, 38(1): 58-64+6.
|
[34]
|
冷欣颖, 邹华春, 付雷雯, 等. 2021美国CDC生殖支原体感染治疗指南读解[J]. 皮肤性病诊疗学杂志, 2021, 28(6): 487-492.
|
[35]
|
Sweeney, E.L., Bradshaw, C.S., Murray, G.L., et al. (2022) Individualised Treatment of Mycoplasma genitalium Infection-Incorporation of Fluoroquinolone Resistance Testing into Clinical Care. The Lancet Infectious Diseases, 22, e267-e270.
https://doi.org/10.1016/S1473-3099(21)00629-0
|
[36]
|
Durukan, D., Doyle, M., Murray, G., et al. (2020) Doxycy-cline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium. Emerging Infectious Diseases, 26, 1870-1874.
https://doi.org/10.3201/eid2608.191806
|
[37]
|
Doyle, M., Vodstrcil, L.A., Plummer, E.L., et al. (2020) Nonquino-lone Options for the Treatment of Mycoplasma genitalium in the Era of Increased Resistance. Open Forum Infectious Diseases, 7, ofaa291.
https://doi.org/10.1093/ofid/ofaa291
|
[38]
|
Mast, Y. and Wohlleben, W. (2014) Streptogramins—Two Are Better than One! International Journal of Medical Microbiology, 304, 44-50. https://doi.org/10.1016/j.ijmm.2013.08.008
|
[39]
|
Bissessor, M., Tabrizi, S.N., Twin, J., et al. (2015) Macrolide Re-sistance and Azithromycin Failure in a Mycoplasma genitalium-Infected Cohort and Response of Azithromycin Failures to Alternative Antibiotic Regimens. Clinical Infectious Diseases, 60, 1228-1236. https://doi.org/10.1093/cid/ciu1162
|
[40]
|
Read, T.R.H., Jensen, J.S., Fairley, C.K., et al. (2018) Use of Pristinamy-cin for Macrolide-Resistant Mycoplasma genitalium Infection. Emerging Infectious Diseases, 24, 328-335. https://doi.org/10.3201/eid2402.170902
|
[41]
|
Lemaire, S., Van Bambeke, F. and Tulkens, P.M. (2009) Cellular Accumulation and Pharmacodynamic Evaluation of the Intracellular Activity of CEM-101, a Novel Fluoroketolide, against Staphylococcus aureus, Listeria monocytogenes, and Legionella pneumophila in Human THP-1 Macrophages. Antimicrobial Agents and Chemotherapy, 53, 3734-3743.
https://doi.org/10.1128/AAC.00203-09
|
[42]
|
Llano-Sotelo, B., Dunkle, J., Klepacki, D., et al. (2010) Binding and Action of CEM-101, a New Fluoroketolide Antibiotic That Inhibits Protein Synthesis. Antimicrobial Agents and Chem-otherapy, 54, 4961-4970.
https://doi.org/10.1128/AAC.00860-10
|
[43]
|
Hook, E.W., Golden, M., Jamieson, B.D., et al. (2015) A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea. Clinical Infectious Diseases, 61, 1043-1048.
https://doi.org/10.1093/cid/civ478
|
[44]
|
Jensen, J.S., Fernandes, P. and Unemo, M. (2014) In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against Macrolide-Resistant and -Susceptible Mycoplasma genitalium Strains. Antimicrobial Agents and Chemotherapy, 58, 3151-3156. https://doi.org/10.1128/AAC.02411-14
|
[45]
|
Dillon, C., Guarascio, A.J. and Covvey, J.R. (2019) Lefamulin: A Promising New Pleuromutilin Antibiotic in the Pipeline. Expert Review of Anti-Infective Therapy, 17, 5-15. https://doi.org/10.1080/14787210.2019.1554431
|
[46]
|
Paukner, S., Gruss, A. and Jensen, J.S. (2018) In Vitro Ac-tivity of Lefamulin against Sexually Transmitted Bacterial Pathogens. Antimicrobial Agents and Chemotherapy, 62, e02380-17. https://doi.org/10.1128/AAC.02380-17
|
[47]
|
Wicha, W.W., Henson, C., Webbley, K., et al. (2022) Tissue Distribution of [(14)C]-Lefamulin into the Urogenital Tract in Rats. Antimicrobial Agents and Chemotherapy, 66, e0035522. https://doi.org/10.1128/aac.00355-22
|
[48]
|
Waites, K.B., Crabb, D.M., Atkinson, T.P., et al. (2022) Omadacycline Is Highly Active in Vitro against Mycoplasma genitalium. Microbiology Spectrum, 10, e0365422.
|
[49]
|
Jones, J.A., Virga, K.G., Gumina, G., et al. (2016) Recent Advances in the Rational Design and Opti-mization of Antibacterial Agents. Medchemcomm, 7, 1694-1715. https://doi.org/10.1039/C6MD00232C
|
[50]
|
Damiao Gouveia, A.C., Unemo, M. and Jensen, J.S. (2018) In Vitro Activity of Zoliflodacin (ETX0914) against Macrolide-Resistant, Fluoroquinolone-Resistant and Antimicrobi-al-Susceptible Mycoplasma genitalium Strains. Journal of Antimicrobial Chemotherapy, 73, 1291-1294. https://doi.org/10.1093/jac/dky022
|
[51]
|
Waites, K.B., Crabb, D.M., Duffy, L.B., et al. (2015) In Vitro Antibacterial Activity of AZD0914 against Human Mycoplasmas and Ureaplasmas. Antimicrobial Agents and Chemotherapy, 59, 3627-3629.
https://doi.org/10.1128/AAC.04945-14
|
[52]
|
Jensen, J.S., Nørgaard, C., Scangarella-Oman, N., et al. (2020) In Vitro Activity of the First-in-Class Triazaacenaphthylene Gepotidacin Alone and in Combination with Doxycycline against Drug-Resistant and -Susceptible Mycoplasma genitalium. Emerging Microbes & Infections, 9, 1388-1392. https://doi.org/10.1080/22221751.2020.1775498
|